Gabapentin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 45865-216
  • Package NDC 45865-216-30
  • Package NDC 45865-216-51
  • Package NDC 45865-216-60
  • Package NDC 45865-216-90
  • Application number ANDA206943
  • SPL ID 1277f18a-a854-3b06-e063-6294a90a88b2
  • SPL set ID 1278512b-1493-db65-e063-6394a90ab161
  • UNII 6CW7F3G59X
  • RxCUI 310430

What the source publishes

Labeler
Medsource Pharmaceuticals
Active ingredients
Gabapentin
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:45865-216_1277f18a-a854-3b06-e063-6294a90a88b2
{
  "name": "Gabapentin",
  "splId": "1277f18a-a854-3b06-e063-6294a90a88b2",
  "labels": [
    {
      "setId": "1278512b-1493-db65-e063-6394a90ab161",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1278512b-1493-db65-e063-6394a90ab161",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1278512b-1493-db65-e063-6394a90ab161"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Medsource Pharmaceuticals",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 CAPSULE in 1 BOTTLE (45865-216-30)",
      "package_ndc": "45865-216-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220915"
    },
    {
      "sample": false,
      "description": "120 CAPSULE in 1 BOTTLE (45865-216-51)",
      "package_ndc": "45865-216-51",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220602"
    },
    {
      "sample": false,
      "description": "60 CAPSULE in 1 BOTTLE (45865-216-60)",
      "package_ndc": "45865-216-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240223"
    },
    {
      "sample": false,
      "description": "90 CAPSULE in 1 BOTTLE (45865-216-90)",
      "package_ndc": "45865-216-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220613"
    }
  ],
  "productId": "45865-216_1277f18a-a854-3b06-e063-6294a90a88b2",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "45865-216",
  "deaSchedule": null,
  "genericName": "Gabapentin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "GABAPENTIN",
      "strength": "100 mg/1"
    }
  ],
  "applicationNumber": "ANDA206943",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20180514",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486"
    ],
    "unii": [
      "6CW7F3G59X"
    ],
    "rxcui": [
      "310430"
    ],
    "spl_set_id": [
      "1278512b-1493-db65-e063-6394a90ab161"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "manufacturer_name": [
      "Medsource Pharmaceuticals"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:45865-216_1277f18a-a854-3b06-e063-6294a90a88b2"